Contrasting Circulating Tumor Cells and Free Circulating DNA Responses in Men Treated for Prostate Cancer after Primary Versus Salvage Radiotherapy
Open Access
- 10 January 2020
- journal article
- research article
- Published by Science Repository OU in Clinical Oncology and Research
- Vol. 2019 (6) , 1-9
Abstract
Purpose: To investigate the relationships between circulating tumor cells (CTCs), free circulating DNA (fcDNA) and biochemical response in prostate cancer patients treated primarily versus salvage radiotherapy (RT). Methods and Materials: Blood was collected prospectively from patients, enrolled in two institutional Phase II trials for primary and salvage RT. Three blood samples were collected at: (i) prior to treatment [RT or androgen deprivation therapy (ADT)], (ii) last week of RT, and (iii) three months post-RT. CTCs were quantified in 31 samples from 12 primary patients and 30 samples from 12 salvage patients; fcDNA were analyzed in 11 primary (28 samples) and 5 (9 samples) salvage patients. CTCs were visualized by immunofluorescence after microfilter capture and fcDNA was quantified using real-time Polymerase chain reaction (PCR). CTCs and fcDNA were correlated with early biochemical response by subdividing patients into early favorable and unfavorable response at 3 months after RT. Results: For those treated primarily, there was a direct correlation with CTC counts and prostate specific antigen (PSA) pre-RT that changed to a reciprocal relationship 3 months post-RT. CTCs increased significantly (p=0.03) at 3 months after primary RT in the biochemical favorable patients, while no significant association was observed for fcDNA. Correspondingly, post-RT fcDNA levels were inversely related to CTC counts. In salvage patients, the number of CTCs was related to pre-RT PSA, but it was not correlated to RT response. In post-RT series, a significant direct correlation was observed between CTCs and PSA. Conclusion: Our preliminary studies suggest that RT affects CTC counts, which are thus associated with prostate cancer biochemical response. A larger cohort with longer follow-up will be needed to establish the association with more recognized treatment endpoints.Keywords
This publication has 28 references indexed in Scilit:
- Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic ReviewEuropean Urology, 2019
- Circulating tumor cells exhibit a biologically aggressive cancer phenotype accompanied by selective resistance to chemotherapyCancer Letters, 2014
- Tracking viable circulating tumor cells (CTCs) in the peripheral blood of non–small cell lung cancer (NSCLC) patients undergoing definitive radiation therapy: Pilot study resultsCancer, 2014
- Mobilization of Viable Tumor Cells Into the Circulation During Radiation TherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2014
- Gleason pattern 5 is the strongest pathologic predictor of recurrence, metastasis, and prostate cancer–specific death in patients receiving salvage radiation therapy following radical prostatectomyCancer, 2013
- The Timing of Salvage Radiotherapy After Radical Prostatectomy: A Systematic ReviewInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Circulating tumour cells in prostate cancer patients receiving salvage radiotherapyClinical and Translational Oncology, 2012
- Predicting Local Persistence of Intermediate and High-risk Prostate Cancer using Percentage of Adenocarcinoma in Pretreatment Biopsy TissueInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- CpG Island Hypermethylation Profile in the Serum of Men With Clinically Localized and Hormone Refractory Metastatic Prostate CancerJournal of Urology, 2008
- Timing of biochemical failure and distant metastatic disease for low‐, intermediate‐, and high‐risk prostate cancer after radiotherapyCancer, 2007